Vascular Biogenics (NASDAQ: VBLT)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Vascular Biogenics (NASDAQ: VBLT) through any online brokerage.
There are no as such competitors for Vascular Biogenics.
The latest price target for Vascular Biogenics (NASDAQ: VBLT) was reported by Chardan Capital on Thursday, April 28, 2022. The analyst firm set a price target for 5.00 expecting VBLT to rise to within 12 months (a possible 177.78% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Vascular Biogenics (NASDAQ: VBLT) is $1.8 last updated July 6, 2022, 8:00 PM UTC.
There are no upcoming dividends for Vascular Biogenics.
Vascular Biogenics’s Q2 earnings are confirmed for Monday, August 15, 2022.
There is no upcoming split for Vascular Biogenics.
Vascular Biogenics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.